DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Geldanamycin
Geldanamycin
Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors
Geldanamycin and Its 17-Allylamino-17-Demethoxy
Cell Surface GRP94 As a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy
Resveratrol Induces Apoptosis in K562 Cells
The Hsp90 Inhibitor Geldanamycin Selectively Sensitizes Bcr-Abl
Cytotoxicity Activity of Geldanamycin Derivatives Against Various Cancer Cell Lines
Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies
Resveratrol Induces Apoptosis in K562 (Chronic Myelogenous
Www .Alfa.Com
Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (KOS-1022, 17-DMAG) Administered Intravenously Twice Weekly to Patients with Acute Myeloid Leukemia
A Novel Hsp90 Inhibitor to Disrupt Hsp90/Cdc37 Complex Against Pancreatic Cancer Cells
17-AAG) on Pediatric Acute Lymphoblastic Leukemia (ALL) with Respect to Bcr-Abl Status and Imatinib Mesylate Sensitivity
Heat Shock Protein 90 Inhibitors Suppress Pyroptosis in THP-1 Cells
Tanespimycin (17-AAG)
In Vitro Study Comparing the Efficacy of the Water
Antiviral Activity of Geldanamycin and Its Derivatives Against Influenza Virus
Inhibition of Cancer Invasion and Metastasis by Targeting the Molecular Chaperone Heat-Shock Protein 90
Discovery and Validation of Small-Molecule Heat-Shock Protein 90 Inhibitors Through Multimodality Molecular Imaging in Living Subjects
Top View
TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells